Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $124.00 (Guggenheim)
- Lowest: $90.00 (Truist Securities)
- Average: $105.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$105.00 (+41.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
Avg. $ Target:
$105.00 (+41.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/10/2025 | H.C. Wainwright » Updated 8/11/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
93.00 (84.00) |
65.31 (74.04) |
13.37% | Details |
| 3/14/2025 | Jefferies » Updated 3/26/2025 |
Glen Santangelo | New Coverage | Buy (N/A) |
80.00 (N/A) |
63.26 (74.04) |
17.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
